Volitionrx (VNRX) Total Debt Growth (3y) (2020 - 2025)
Volitionrx (VNRX) Total Debt Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | 0.11% |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | -0.32% |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | 5.42% |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | 2.61% |
| 10 | Volitionrx | 99,574.04 | -1.02 Mn | - | 20.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.38% |
| Sep 30, 2025 | 24.72% |
| Jun 30, 2025 | 40.27% |
| Mar 31, 2025 | 29.20% |
| Dec 31, 2024 | 16.19% |
| Sep 30, 2024 | 27.43% |
| Jun 30, 2024 | 8.30% |
| Dec 31, 2023 | 11.90% |
| Mar 31, 2023 | 3.73% |
| Dec 31, 2022 | 10.60% |
| Sep 30, 2022 | 5.13% |
| Jun 30, 2022 | -7.41% |
| Dec 31, 2021 | 8.52% |
| Mar 31, 2020 | 183.30% |